- Home
- TGL vs ONCO Comparison
TGL vs ONCO Comparison
Compare TGL & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- ONCO
- Stock Information
- Founded
- TGL 2020
- ONCO 2018
- Country
- TGL United States
- ONCO United States
- Employees
- TGL N/A
- ONCO N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- TGL Technology
- ONCO Health Care
- Exchange
- TGL Nasdaq
- ONCO Nasdaq
- Market Cap
- TGL 4.1M
- ONCO 4.7M
- IPO Year
- TGL 2022
- ONCO 2022
- Fundamental
- Price
- TGL $0.74
- ONCO $3.56
- Analyst Decision
- TGL
- ONCO
- Analyst Count
- TGL 0
- ONCO 0
- Target Price
- TGL N/A
- ONCO N/A
- AVG Volume (30 Days)
- TGL 5.5M
- ONCO 68.8K
- Earning Date
- TGL 10-15-2025
- ONCO 12-09-2025
- Dividend Yield
- TGL N/A
- ONCO N/A
- EPS Growth
- TGL N/A
- ONCO N/A
- EPS
- TGL N/A
- ONCO N/A
- Revenue
- TGL $2,330,557.00
- ONCO $1,326,959.00
- Revenue This Year
- TGL N/A
- ONCO N/A
- Revenue Next Year
- TGL N/A
- ONCO N/A
- P/E Ratio
- TGL N/A
- ONCO N/A
- Revenue Growth
- TGL N/A
- ONCO N/A
- 52 Week Low
- TGL $0.70
- ONCO $2.45
- 52 Week High
- TGL $39.00
- ONCO $325.55
- Technical
- Relative Strength Index (RSI)
- TGL 35.68
- ONCO 54.62
- Support Level
- TGL $0.73
- ONCO $3.31
- Resistance Level
- TGL $1.17
- ONCO $3.68
- Average True Range (ATR)
- TGL 0.10
- ONCO 0.24
- MACD
- TGL -0.02
- ONCO -0.02
- Stochastic Oscillator
- TGL 6.33
- ONCO 33.00
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.